Terms: = Germ cell tumor AND HMGA1, MGC4242, 3159, ENSG00000137309, MGC12816, HMGIY, P17096, MGC4854, HMG-R AND Treatment
14 results:
1. The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by hmga1.
Salatino A; Mirabelli M; Chiefari E; Greco M; Di Vito A; Bonapace G; Brunetti FS; Crocerossa F; Epstein AL; Foti DP; Brunetti A
Front Endocrinol (Lausanne); 2022; 13():1051988. PubMed ID: 36506071
[TBL] [Abstract] [Full Text] [Related]
2. Can a signature molecular-profile define disparate survival in BRAF-positive Gliosarcoma and identify novel targets for therapeutic intervention?
Gandhi P; Khare R; Garg N; Mishra J
J Cancer Res Ther; 2022; 18(1):224-230. PubMed ID: 35381788
[TBL] [Abstract] [Full Text] [Related]
3. Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers.
Dobrotkova V; Chlapek P; Jezova M; Adamkova K; Mazanek P; Sterba J; Veselska R
PLoS One; 2019; 14(6):e0218269. PubMed ID: 31188873
[TBL] [Abstract] [Full Text] [Related]
4. tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration.
Zaatiti H; Abdallah J; Nasr Z; Khazen G; Sandler A; Abou-Antoun TJ
Int J Oncol; 2018 Mar; 52(3):787-803. PubMed ID: 29328367
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of Ki67, hmga1, MDM2, and RB expression in nonfunctioning pituitary adenomas.
Yao X; Gao H; Li C; Wu L; Bai J; Wang J; Li Y; Zhang Y
J Neurooncol; 2017 Apr; 132(2):199-206. PubMed ID: 28255749
[TBL] [Abstract] [Full Text] [Related]
6. High mobility group A1 expression shows negative correlation with recurrence time in patients with glioblastoma multiforme.
Liu B; Pang B; Liu H; Arakawa Y; Zhang R; Feng B; Zhong P; Murata D; Fan H; Xin T; Zhao G; Liu W; Guo H; Luan L; Xu S; Miyamoto S; Pang Q
Pathol Res Pract; 2015 Aug; 211(8):596-600. PubMed ID: 26092597
[TBL] [Abstract] [Full Text] [Related]
7. Recent advances in molecular and cell biology of testicular germ-cell tumors.
Chieffi P
Int Rev Cell Mol Biol; 2014; 312():79-100. PubMed ID: 25262239
[TBL] [Abstract] [Full Text] [Related]
8. An up-date on newly discovered immunohistochemical biomarkers for the diagnosis of human testicular germ cell tumors.
Chieffi P; Chieffi S
Histol Histopathol; 2014 Aug; 29(8):999-1006. PubMed ID: 24627150
[TBL] [Abstract] [Full Text] [Related]
9. Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: an overview.
Chieffi P; Chieffi S
J Cell Physiol; 2013 Aug; 228(8):1641-6. PubMed ID: 23359388
[TBL] [Abstract] [Full Text] [Related]
10. Using a modified far-lateral approach to remove hypoglossal neurilemmomas: notes on technique.
Xiao X; Wu Z; Zhang L; Jia G; Tang J; Meng G; Zhang J
J Neurosurg; 2013 Mar; 118(3):657-68. PubMed ID: 23082881
[TBL] [Abstract] [Full Text] [Related]
11. New prognostic markers and potential therapeutic targets in human testicular germ cell tumors.
Chieffi P
Curr Med Chem; 2011; 18(33):5033-40. PubMed ID: 22050751
[TBL] [Abstract] [Full Text] [Related]
12. Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.
Kang WD; Choi HS; Kim SM
Gynecol Oncol; 2010 Jun; 117(3):477-80. PubMed ID: 20347479
[TBL] [Abstract] [Full Text] [Related]
13. High mobility group A1 is a molecular target for MYCN in human neuroblastoma.
Giannini G; Cerignoli F; Mellone M; Massimi I; Ambrosi C; Rinaldi C; Dominici C; Frati L; Screpanti I; Gulino A
Cancer Res; 2005 Sep; 65(18):8308-16. PubMed ID: 16166307
[TBL] [Abstract] [Full Text] [Related]
14. treatment outcome of patients with brain metastases from malignant germ cell tumors.
Fosså SD; Bokemeyer C; Gerl A; Culine S; Jones WG; Mead GM; Germa-Luch JR; Pont J; Schmoll HJ; Tjulandin S
Cancer; 1999 Feb; 85(4):988-97. PubMed ID: 10091779
[TBL] [Abstract] [Full Text] [Related]
